Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in China:
Xiangxue Pharmaceutical Co Ltd
(2017
sales of 2.19 billion Chinese Renmimbi [US$315.91 million]
of which 37%
was Chinese Herbal Medicines),
Anhui Fengyuan Pharmaceutical
(2.58 billion Chinese Renmimbi [US$372.36 million]
of which 58%
was Medicine Retail Circulation), and
Guangxi Wuzhou Zhongheng Group, Ltd.
(2.05 billion Chinese Renmimbi [US$295.55 million]
of which 93%
was Pharmaceutical Segment).
Sales Analysis.
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.31 billion Chinese Renmimbi (US$333.48 million)
for the
year ending
December of 2017.
This
represents
a
decrease of 5.1%
versus 2016, when the company's sales were 2.43 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 10.7% decline
in Dyes, from 1.20 billion Chinese Renmimbi to 1.08 billion Chinese Renmimbi.
.
However, these declines were partially offset by the increase in sales of
Pharmatheutical Industry (up 2.7% to 1.29 billion Chinese Renmimbi)
.